Back to search
Autosomal Dominant Hypocalcemia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Autosomal Dominant Hypocalcemia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Autosomal Dominant Hypocalcemia trials you may qualify forThe overall objective of this study is to evaluate the pharmacokinetics (PK), efficacy, and safety of encaleret in pediatric participants from birth to 17 years…
The goal of this National Registry is to is to collect information from patients with rare kidney diseases, so that it that can be used for research. The purpo…
A global, multi-center, Disease Monitoring Study (DMS) in participants with Autosomal Dominant Hypocalcemia Type 1 (ADH1) or Autosomal Dominant Hypocalcemia Typ…
This randomized crossover study will evaluate the safety, efficacy, and pharmacodynamics of synthetic human PTH 1-34 (PTH) delivered by an insulin pump (omnipod…
The primary purpose of the study is to understand the effectiveness, safety, and tolerability of encaleret when compared to standard of care (SoC) treatment in…